Recently, the Sina Finance ESG Rating Center, in collaboration with CCTV-1's "National Brand" program, released the first "Top 500 Chinese ESG Excellent Enterprises" list at the Golden Kirin Forum. Healthy Yuan Pharmaceutical Group (600380.SH) and its subsidiary, Lizhu Group (000513.SZ), ranked 24th and 28th respectively on this list.
In today's pursuit of high-quality development, single financial indicators can no longer fully reflect a company's sustainable development capabilities and competitiveness. Enterprises need to create more social and economic value around social issues such as environmental protection, climate governance, social responsibility, and common prosperity, focusing on upgrading their value concepts.
This selection did not rely on the data results of a single rating agency. Instead, it systematically analyzed the rating systems of multiple authoritative institutions, evaluating nearly 50 key issues and approximately 450 specific indicators across the three dimensions of E, S, and G. The indicators comprehensively covered environmental data such as corporate carbon emissions, resource utilization, and waste disposal; social responsibility data such as employee training and development, supply chain management, anti-corruption, and charitable donations; and corporate governance data such as the board of directors, compensation system, business ethics, and tax transparency. Finally, the ESG rating data from six domestic and international rating agencies and relevant data publicly released by several think tanks were selected as data sources. A comprehensive score was generated through data standardization and weight redistribution. The organizers selected the top 500 companies based on the evaluation results and released them as the "Top 500 Chinese ESG Excellent Enterprises" list.
Healthy Yuan Pharmaceutical Group's sustainable development management has attracted considerable attention. In this year's MSCI ESG rating, Healthy Yuan saw improved scores in environmental protection, human capital development, and inclusive health, resulting in an overall rating upgrade to BBB. This reflects the capital market's high recognition and confidence in Healthy Yuan's corporate strength and development philosophy.
After nearly thirty years of development, Healthy Yuan Group has successfully undergone transformation and upgrading. It will adhere to technological innovation as its strategic cornerstone and will focus on building innovative drug and high-end barrier complex preparation technology platforms as its most important future strategic goals. In recent years, Healthy Yuan's respiratory preparations have been continuously launched onto the market, making it one of the few domestic companies with a comprehensive layout in respiratory preparations and leading research and development progress. This has broken the monopoly of international original research drug manufacturers. While its main business is thriving, Healthy Yuan actively practices social responsibility, actively participates in social welfare undertakings, pays attention to the accessibility, affordability, and rational use of medical products and services, actively responds to national medical insurance catalog entry and negotiation work, strives to provide patients with high-quality medicines at reasonable prices, and continuously promotes the development of the greater health industry.
Meanwhile, Healthy Yuan and its subsidiary Lizhu Group have jointly launched a special rural revitalization project for chronic disease patients, donating chronic disease treatment drugs to elderly patients with hypertension, hyperlipidemia, and cardiovascular diseases in areas in need of assistance. This project has already benefited thousands of chronic disease patient families, bringing tangible health benefits to the people.
Although ESG is relatively new in China, its core ideas are consistent with China's long-term sustainable development strategy and are an important tool for implementing the new development philosophy and promoting high-quality economic development. Therefore, the management and efforts of enterprises in ESG concepts and sustainable development will also feed back into the enterprises, promoting lean management and improving corporate governance.
